A Multicenter, Randomized, Double-Blind, Active and Placebo Controlled, Phase III Efficacy and Safety Study of Oxycodone HCI and Low-Dose Naltrexone HCI (PTI-801) in Patients with Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee